Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Yarrow Bioscience, Inc. clinical trials
Also known as VYNE, Menlo Therapeutics.
The registry lists 33 studies whose lead sponsor is Yarrow Bioscience, Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 5, 2026.
Keep track of what changes. Save the Yarrow Bioscience, Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Yarrow Bioscience, Inc..
- Vyne Therapeutics Inc.32 studiesSame company
Something wrong?
- Yarrow Bioscience, Inc.1 studySame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 33 of 33.
- Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' DiseaseRecruitingNCT07682896Phase 2
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.TerminatedNCT06493578Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic DermatitisCompletedNCT04927572Phase 1/2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- VPD-737 for Treatment of Chronic PruritusCompletedNCT01951274Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe AcneCompletedNCT02815280Phase 3
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe AcneCompletedNCT02815267Phase 3
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne VulgarisCompletedNCT03271021Phase 3
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular RosaceaCompletedNCT03276936Phase 3
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown OriginCompletedNCT03841331Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)TerminatedNCT03540160Phase 3
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic CoughCompletedNCT03282591Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo NodularisCompletedNCT03677401Phase 3
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)CompletedNCT02196324Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo NodularisCompletedNCT03546816Phase 3
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Study of MK0594 in Patients With Alcohol Dependence (0594-020)TerminatedNCT00835718Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque PsoriasisCompletedNCT03343639Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic DermatitisCompletedNCT02975206Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn InjuryTerminatedNCT02975271Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)CompletedNCT00290563Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Study Comparing Two Topicals in the Treatment of Acne VulgarisCompletedNCT03743038Phase 1
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Pharmacokinetic Study of Minocycline in Male and Female VolunteersCompletedNCT02250859Phase 1
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.CompletedNCT04104685Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular RosaceaCompletedNCT03142451Phase 3
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular RosaceaCompletedNCT04608500Phase 3
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Dermal Phototoxicity StudyCompletedNCT04070742Phase 1
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Dermal Cumulative Irritant Patch StudyCompletedNCT04064125Phase 1
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Dermal Photo Allergic Skin ReactionCompletedNCT04070755Phase 1
Sponsor listed in the registry: Vyne Therapeutics Inc.
- A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test DesignCompletedNCT04052711Phase 1
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer PatientsCompletedNCT02239731Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular RosaceaCompletedNCT02601963Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea PatientsTerminatedNCT01134991Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo PatientsCompletedNCT01171326Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.
- Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris PatientsCompletedNCT01362010Phase 2
Sponsor listed in the registry: Vyne Therapeutics Inc.